Subarachnoid Hemorrhage and Soluble Epoxide Hydrolase Inhibition Trial

NCT03318783 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Subarachnoid Hemorrhage, Aneurysmal
Delayed Cerebral Ischemia
Vasospasm, Cerebral
Endothelial Dysfunction

Interventions

DRUG: GSK2256294
DRUG: Placebo

Sponsor

Oregon Health and Science University

Collaborators

[object Object]
[object Object]